Segmental cardiac radiation dose determines magnitude of regional cardiac dysfunction

17Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: Subclinical left ventricular dysfunction detected by 2-dimensional global longitudinal strain post breast radiotherapy has been described in patients with breast cancer. We hypothesized that left ventricular dysfunction postradiotherapy may be site specific, based on differential segmental radiotherapy dose received. METHODS AND RESULTS: Transthoracic echocardiograms were performed at baseline, 6 weeks, and 12 months postradio-therapy on 61 chemotherapy-naïve women with left-sided breast cancer undergoing tangential breast radiotherapy. Radiation received within basal, mid, and apical regions for the 6 left ventricular walls was quantified from the radiotherapy treatment planning system. Anterior, anteroseptal, and anterolateral walls received the highest radiation doses, while inferolateral and inferior walls received the lowest. There was a progressive increase in the radiation dose received from basal to apical regions. At 6 weeks, the most significant percentage deterioration in strain was seen in the apical region, with greatest reductions in the anterior wall followed by the anteroseptal and anterolateral walls, with a similar pattern persisting at 12 months. There was a within-patient dose–response association between the segment-specific percentage deterioration in strain at 6 weeks and 12 months and the radiation dose received. CONCLUSIONS: Radiotherapy for left-sided breast cancer causes differential segmental dysfunction, with myocardial segments that receive the highest radiation dose demonstrating greatest strain impairment. Percentage deterioration in strain observed 6 weeks postradiotherapy persisted at 12 months and demonstrated a dose–response relationship with radiotherapy dose re-ceived. Radiotherapy-induced subclinical cardiac dysfunction is of importance because it could be additive to chemotherapy-related cardiotoxicity in patients with breast cancer. Long-term outcomes in patients with asymptomatic strain reduction require further investigation.

References Powered by Scopus

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

66844Citations
N/AReaders
Get full text

Recommendations for chamber quantification

3089Citations
N/AReaders
Get full text

Risk of ischemic heart disease in women after radiotherapy for breast cancer

3083Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The cardiac toxicity of radiotherapy–a review of characteristics, mechanisms, diagnosis, and prevention

27Citations
N/AReaders
Get full text

Radiation-induced heart disease

26Citations
N/AReaders
Get full text

Radiotherapy-Induced Cardiotoxicity: The Role of Multimodality Cardiovascular Imaging

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Trivedi, S. J., Tang, S., Byth, K., Stefani, L., Lo, Q., Otton, J., … Thomas, L. (2021). Segmental cardiac radiation dose determines magnitude of regional cardiac dysfunction. Journal of the American Heart Association, 10(7). https://doi.org/10.1161/JAHA.120.019476

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

50%

Researcher 2

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

75%

Economics, Econometrics and Finance 1

25%

Article Metrics

Tooltip
Mentions
News Mentions: 2

Save time finding and organizing research with Mendeley

Sign up for free